chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Skin warm
Clinical narrative: Sore arm; fatigue; little tired; feeling achy; Covid arm; a rash that is warm ,red, and itchy; a rash that is warm ,red, and itchy; a rash that is warm ,red, and itchy; second dose on 4Mar2021 in my right arm which is a 34 days difference.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), SKIN WARM (a rash that is warm ,red, and itchy), FATIGUE (fatigue), ERYTHEMA (a rash that is warm ,red, and itchy) and FATIGUE (little tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on 4Mar2021 in my right arm which is a 34 days difference.). On 09-Mar-2021, the patient experienced SKIN WARM (a rash that is warm ,red, and itchy), ERYTHEMA (a rash that is warm ,red, and itchy), COVID-19 (Covid arm) and PRURITUS (a rash that is warm ,red, and itchy). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). an unknown date, the patient experienced FATIGUE (fatigue), FATIGUE (little tired) and PAIN (feeling achy). On 04-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on 4Mar2021 in my right arm which is a 34 days difference.) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), SKIN WARM (a rash that is warm ,red, and itchy), FATIGUE (fatigue), ERYTHEMA (a rash that is warm ,red, and itchy), FATIGUE (little tired), PAIN (feeling achy), COVID-19 (Covid arm) and PRURITUS (a rash that is warm ,red, and itchy) outcome was unknown. Not Provided          No relevant concomitant medications provided. No relevant Treatment information provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Skin burning sensation
Clinical narrative: Burning sensation skin; a series of rashes on the back of my hands, fingers, ankles ,lower wrist and forearm; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (Burning sensation skin) and RASH (a series of rashes on the back of my hands, fingers, ankles ,lower wrist and forearm) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 029K20A) for COVID-19 vaccination.     No past medical history was provided.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced SKIN BURNING SENSATION (Burning sensation skin) and RASH (a series of rashes on the back of my hands, fingers, ankles ,lower wrist and forearm). At the time of the report, SKIN BURNING SENSATION (Burning sensation skin) outcome was unknown and RASH (a series of rashes on the back of my hands, fingers, ankles ,lower wrist and forearm) had not resolved.            No concomitant medication was reported. Treatment information was included topical cream prescribed by dermatologist for a week.    Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non-significant follow up appended
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Peripheral swelling
Clinical narrative: right arm was red; right arm felt hot; right arm felt swollen; soreness in her right arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in her right arm), PERIPHERAL SWELLING (right arm felt swollen), ERYTHEMA (right arm was red) and FEELING HOT (right arm felt hot) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in her right arm). On 06-Mar-2021, the patient experienced PERIPHERAL SWELLING (right arm felt swollen). On 10-Mar-2021, the patient experienced ERYTHEMA (right arm was red) and FEELING HOT (right arm felt hot). On 26-Feb-2021, PAIN IN EXTREMITY (soreness in her right arm) had resolved. At the time of the report, PERIPHERAL SWELLING (right arm felt swollen), ERYTHEMA (right arm was red) and FEELING HOT (right arm felt hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyskinesia, Fatigue, Feeling cold, Neurological symptom
Clinical narrative: Fatigue; involuntary muscle movement on left middle forearm on the pinkie side down by his wrist, felt like a thump thump (not muscle but nerve); diarrhea; felt cold; nerve reaction; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), DYSKINESIA (involuntary muscle movement on left middle forearm on the pinkie side down by his wrist, felt like a thump thump (not muscle but nerve)), DIARRHOEA (diarrhea), FEELING COLD (felt cold) and NEUROLOGICAL SYMPTOM (nerve reaction) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE, ATORVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ), ACETYLSALICYLIC ACID (ASPIRIN 81) and NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for an unknown indication.    On 08-Mar-2021 at 6:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced FATIGUE (Fatigue), DYSKINESIA (involuntary muscle movement on left middle forearm on the pinkie side down by his wrist, felt like a thump thump (not muscle but nerve)), DIARRHOEA (diarrhea), FEELING COLD (felt cold) and NEUROLOGICAL SYMPTOM (nerve reaction). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Mar-2021, FATIGUE (Fatigue), DIARRHOEA (diarrhea) and FEELING COLD (felt cold) had resolved. On 09-Mar-2021, DYSKINESIA (involuntary muscle movement on left middle forearm on the pinkie side down by his wrist, felt like a thump thump (not muscle but nerve)) and NEUROLOGICAL SYMPTOM (nerve reaction) had resolved. Not Provided
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: Patient did not receive the second dose with in 42 days after the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of OFF LABEL USE (Patient did not receive the second dose with in 42 days after the first dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Patient did not receive the second dose with in 42 days after the first dose). At the time of the report, OFF LABEL USE (Patient did not receive the second dose with in 42 days after the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Urticaria
Clinical narrative: Red Welt; Red Circle diameter is 4inches does not hurt/Outer ring of Red circle is a darker red ring; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Red Welt) and ERYTHEMA (Red Circle diameter is 4inches does not hurt/Outer ring of Red circle is a darker red ring) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced URTICARIA (Red Welt) and ERYTHEMA (Red Circle diameter is 4inches does not hurt/Outer ring of Red circle is a darker red ring). At the time of the report, URTICARIA (Red Welt) and ERYTHEMA (Red Circle diameter is 4inches does not hurt/Outer ring of Red circle is a darker red ring) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information use was not reported.  Treatment information was not provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: chills; muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and MYALGIA (muscle soreness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A20A and 031L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, LISINOPRIL and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced CHILLS (chills) and MYALGIA (muscle soreness). At the time of the report, CHILLS (chills) and MYALGIA (muscle soreness) outcome was unknown.            No treatment medications were provided by the reporter.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal distension, Decreased appetite, Headache, Malaise
Clinical narrative: arm pain; malaise; Fever; banging headache; gastric upset; abdomen has been swollen; appetite has been suppressed/ significant reduced appetite/ slight anorexia; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (arm pain), ABDOMINAL DISTENSION (abdomen has been swollen), DECREASED APPETITE (appetite has been suppressed/ significant reduced appetite/ slight anorexia), MALAISE (malaise) and ABDOMINAL DISCOMFORT (gastric upset) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Irritable bowel syndrome. Concurrent medical conditions included Allergy to antibiotic (minocycline). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 09-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced ABDOMINAL DISTENSION (abdomen has been swollen), DECREASED APPETITE (appetite has been suppressed/ significant reduced appetite/ slight anorexia) and ABDOMINAL DISCOMFORT (gastric upset). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (arm pain), MALAISE (malaise), PYREXIA (Fever) and HEADACHE (banging headache). In March 2021, ABDOMINAL DISTENSION (abdomen has been swollen), DECREASED APPETITE (appetite has been suppressed/ significant reduced appetite/ slight anorexia) and ABDOMINAL DISCOMFORT (gastric upset) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), MALAISE (malaise), PYREXIA (Fever) and HEADACHE (banging headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided by the reporter.   This case was linked to MOD21-050421 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: No specific follow-up information recorded.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: arm pain; malaise; Fever; banging headache; gastric upset; abdomen has been swollen; appetite has been suppressed/ significant reduced appetite/ slight anorexia; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (arm pain), ABDOMINAL DISTENSION (abdomen has been swollen), DECREASED APPETITE (appetite has been suppressed/ significant reduced appetite/ slight anorexia), MALAISE (malaise) and ABDOMINAL DISCOMFORT (gastric upset) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Irritable bowel syndrome. Concurrent medical conditions included Allergy to antibiotic (minocycline). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 09-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced ABDOMINAL DISTENSION (abdomen has been swollen), DECREASED APPETITE (appetite has been suppressed/ significant reduced appetite/ slight anorexia) and ABDOMINAL DISCOMFORT (gastric upset). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (arm pain), MALAISE (malaise), PYREXIA (Fever) and HEADACHE (banging headache). In March 2021, ABDOMINAL DISTENSION (abdomen has been swollen), DECREASED APPETITE (appetite has been suppressed/ significant reduced appetite/ slight anorexia) and ABDOMINAL DISCOMFORT (gastric upset) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), MALAISE (malaise), PYREXIA (Fever) and HEADACHE (banging headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided by the reporter.   This case was linked to MOD21-050421 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: No specific follow-up information recorded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Dizziness, Feeling abnormal, Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (generally miserable), DIZZINESS (she is lightheaded), PAIN IN EXTREMITY (she has had a sore arm), HEADACHE (really a bad headache/ periodically a headache on left side of her head) and VACCINATION SITE PAIN (she still feels a burning pain on her left arm (injection site)) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Thyroid disorder NOS (Thyroid shut down). Previously administered products included for COVID-19: Augmentin (She claims that the Augmentin that she was prescribed with during that time screwed up her guts) in February 2020. Past adverse reactions to the above products included Abdominal disorder with Augmentin. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (generally miserable), HEADACHE (really a bad headache/ periodically a headache on left side of her head) and ARTHRALGIA (joint aches). On 10-Mar-2021, the patient experienced DIZZINESS (she is lightheaded) and PAIN IN EXTREMITY (she has had a sore arm). On an unknown date, the patient experienced VACCINATION SITE PAIN (she still feels a burning pain on her left arm (injection site)). At the time of the report, FEELING ABNORMAL (generally miserable), DIZZINESS (she is lightheaded), PAIN IN EXTREMITY (she has had a sore arm), HEADACHE (really a bad headache/ periodically a headache on left side of her head) and ARTHRALGIA (joint aches) outcome was unknown and VACCINATION SITE PAIN (she still feels a burning pain on her left arm (injection site)) had not resolved.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature: 100.5 f High. No concomitant medications were reported. No treatment medications were provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Updated patient demographics, medical history and added new event.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (generally miserable), DIZZINESS (she is lightheaded), PAIN IN EXTREMITY (she has had a sore arm), HEADACHE (really a bad headache/ periodically a headache on left side of her head) and VACCINATION SITE PAIN (she still feels a burning pain on her left arm (injection site)) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Thyroid disorder NOS (Thyroid shut down). Previously administered products included for COVID-19: Augmentin (She claims that the Augmentin that she was prescribed with during that time screwed up her guts) in February 2020. Past adverse reactions to the above products included Abdominal disorder with Augmentin. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (generally miserable), HEADACHE (really a bad headache/ periodically a headache on left side of her head) and ARTHRALGIA (joint aches). On 10-Mar-2021, the patient experienced DIZZINESS (she is lightheaded) and PAIN IN EXTREMITY (she has had a sore arm). On an unknown date, the patient experienced VACCINATION SITE PAIN (she still feels a burning pain on her left arm (injection site)). At the time of the report, FEELING ABNORMAL (generally miserable), DIZZINESS (she is lightheaded), PAIN IN EXTREMITY (she has had a sore arm), HEADACHE (really a bad headache/ periodically a headache on left side of her head) and ARTHRALGIA (joint aches) outcome was unknown and VACCINATION SITE PAIN (she still feels a burning pain on her left arm (injection site)) had not resolved.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature: 100.5 f High. No concomitant medications were reported. No treatment medications were provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Updated patient demographics, medical history and added new event.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Erythema, Pain in extremity
Clinical narrative: Dry mouth; sore arm; redness; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included GABAPENTIN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DRY MOUTH (Dry mouth), PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness). At the time of the report, DRY MOUTH (Dry mouth), PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For treatment, patient used over the counter muscle rub and some biotin contain wash for topical use.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Gait inability, Headache, Musculoskeletal stiffness, Pyrexia
Clinical narrative: She developed a hot rash in it below injection site; She developed a hot rash fever in it below injection site; Headache; Legs were very stiff; States that she had to crawl up the stairs; Chest congestion; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Legs were very stiff), GAIT INABILITY (States that she had to crawl up the stairs), CHEST DISCOMFORT (Chest congestion), VACCINATION SITE RASH (She developed a hot rash in it below injection site) and VACCINATION SITE WARMTH (She developed a hot rash fever in it below injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Legs were very stiff), GAIT INABILITY (States that she had to crawl up the stairs), CHEST DISCOMFORT (Chest congestion) and HEADACHE (Headache). On 10-Mar-2021, the patient experienced VACCINATION SITE RASH (She developed a hot rash in it below injection site) and VACCINATION SITE WARMTH (She developed a hot rash fever in it below injection site). At the time of the report, MUSCULOSKELETAL STIFFNESS (Legs were very stiff), GAIT INABILITY (States that she had to crawl up the stairs), CHEST DISCOMFORT (Chest congestion), VACCINATION SITE RASH (She developed a hot rash in it below injection site), VACCINATION SITE WARMTH (She developed a hot rash fever in it below injection site) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: up to 102.5 up to 102.5.         No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site warmth
Clinical narrative: She developed a hot rash in it below injection site; She developed a hot rash fever in it below injection site; Headache; Legs were very stiff; States that she had to crawl up the stairs; Chest congestion; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Legs were very stiff), GAIT INABILITY (States that she had to crawl up the stairs), CHEST DISCOMFORT (Chest congestion), VACCINATION SITE RASH (She developed a hot rash in it below injection site) and VACCINATION SITE WARMTH (She developed a hot rash fever in it below injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Legs were very stiff), GAIT INABILITY (States that she had to crawl up the stairs), CHEST DISCOMFORT (Chest congestion) and HEADACHE (Headache). On 10-Mar-2021, the patient experienced VACCINATION SITE RASH (She developed a hot rash in it below injection site) and VACCINATION SITE WARMTH (She developed a hot rash fever in it below injection site). At the time of the report, MUSCULOSKELETAL STIFFNESS (Legs were very stiff), GAIT INABILITY (States that she had to crawl up the stairs), CHEST DISCOMFORT (Chest congestion), VACCINATION SITE RASH (She developed a hot rash in it below injection site), VACCINATION SITE WARMTH (She developed a hot rash fever in it below injection site) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: up to 102.5 up to 102.5.         No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (Chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0ZA21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced CHILLS (Chills). On 10-Mar-2021 at 5:00 AM, CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included natural pills.  Treatment information was was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: injection site very  swollen; injection site very red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection site very  swollen) and INJECTION SITE ERYTHEMA (injection site very red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (injection site very  swollen) and INJECTION SITE ERYTHEMA (injection site very red). At the time of the report, INJECTION SITE SWELLING (injection site very  swollen) and INJECTION SITE ERYTHEMA (injection site very red) outcome was unknown.            No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: Mild fever; slight chills; tired; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Mar-2021. The most recent information was received on 25-Jun-2021 and was forwarded to Moderna on 25-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Mild fever), CHILLS (slight chills) and FATIGUE (tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Fatty liver, Diabetic, Overweight, Adrenal disorder NOS, Arthritis (no cartilage on her knees at all), Poor peripheral circulation, Renal cyst (left kidney), Eye disorder NOS and Cancer (NOS).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced CHILLS (slight chills) and FATIGUE (tired). On an unknown date, the patient experienced PYREXIA (Mild fever). The patient was treated with LEVOCABASTINE HYDROCHLORIDE (ZYRTEC [LEVOCABASTINE HYDROCHLORIDE]) on 08-Mar-2021 for Adverse event, at a dose of 1 dosage form and LORATADINE (CLARITIN [LORATADINE]) on 08-Mar-2021 for Adverse event, at a dose of 1 dosage form. On 02-Mar-2021, CHILLS (slight chills) and FATIGUE (tired) had resolved. At the time of the report, PYREXIA (Mild fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  The patient subsequently realized that the events of skin irritation all over her body; her right arm was itchy, she scratched and looked and she had like 5 or 6 bumps in a row; and bumps on her arms, fingers and left side of her body, toes, stomach, chest and above her right breast, forehead, down hairline, face, neck, even palms of her hands were due to bed bug bites (events removed). The only adverse reaction she had to the vaccine was slight chills, mild fever, and tiredness.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: F/U-1 : Patient initials updated. Event added; some adverse events removed.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pruritus, Swelling
Clinical narrative: soreness; redness; swelling; itchyness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), ERYTHEMA (redness), SWELLING (swelling) and PRURITUS (itchyness) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), NYSTATIN (STATIN [NYSTATIN]) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (soreness), ERYTHEMA (redness), SWELLING (swelling) and PRURITUS (itchyness). At the time of the report, PAIN (soreness), ERYTHEMA (redness), SWELLING (swelling) and PRURITUS (itchyness) outcome was unknown.            No treatment medication was reported.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphonia, Ear infection, Neck pain
Clinical narrative: ear infection; Sore neck; Hoarse voice; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EAR INFECTION (ear infection), NECK PAIN (Sore neck) and DYSPHONIA (Hoarse voice) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced NECK PAIN (Sore neck) and DYSPHONIA (Hoarse voice). On an unknown date, the patient experienced EAR INFECTION (ear infection). At the time of the report, EAR INFECTION (ear infection) outcome was unknown and NECK PAIN (Sore neck) and DYSPHONIA (Hoarse voice) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The patient took Tylenol as treatment medication.  The patient went to see the doctor, and his doctor diagnosed him with an ear infection. His doctor reported his sore neck and hoarseness were due to ear infection.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Patient diagnosed with ear infection.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site swelling, Pain in extremity
Clinical narrative: The arm sore for about two days and a week after the injection site swelled up again; The arm sore for about two days and a week after the injection site swelled up again; A spontaneous report was received from a consumer concerning a 79-years-old male patient who experienced events arm sore for about two days (pain in extremity) and a week after the injection site swelled up again (injection site swelling).   The patient's medical history was not provided. No relevant concomitant medications were reported.  On 12 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot number: 031620A) intramuscularly for prophylaxis of COVID-19 infection.  On 12 Feb 2021, the patient experienced the event(s) arm sore for about two days and a week after the injection site swelled up again.   Treatment details included cold compress and paracetamol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, arm sore for about two days (pain in extremity) was recovered/resolved  on an unknown date, The outcome of the event, and a week after the injection site swelled up again (injection site swelling) was not recovered/not resolved at the time of reporting.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Headache, Pain
Clinical narrative: triouble breathing; itchy throat that progressed to a little cough; itchy throat that progressed to a little cough; body aches; fever; covid at the time of the first dose; headache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid at the time of the first dose), THROAT IRRITATION (itchy throat that progressed to a little cough), COUGH (itchy throat that progressed to a little cough), PAIN (body aches) and DYSPNOEA (triouble breathing) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced COVID-19 (covid at the time of the first dose) and HEADACHE (headache). On 12-Jan-2021, the patient experienced THROAT IRRITATION (itchy throat that progressed to a little cough), COUGH (itchy throat that progressed to a little cough), PAIN (body aches) and PYREXIA (fever). On an unknown date, the patient experienced DYSPNOEA (triouble breathing). At the time of the report, COVID-19 (covid at the time of the first dose), THROAT IRRITATION (itchy throat that progressed to a little cough), COUGH (itchy throat that progressed to a little cough), PAIN (body aches), DYSPNOEA (triouble breathing), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided Treatment medication includes Z-PAK, albuterol pump
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Throat irritation
Clinical narrative: triouble breathing; itchy throat that progressed to a little cough; itchy throat that progressed to a little cough; body aches; fever; covid at the time of the first dose; headache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid at the time of the first dose), THROAT IRRITATION (itchy throat that progressed to a little cough), COUGH (itchy throat that progressed to a little cough), PAIN (body aches) and DYSPNOEA (triouble breathing) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced COVID-19 (covid at the time of the first dose) and HEADACHE (headache). On 12-Jan-2021, the patient experienced THROAT IRRITATION (itchy throat that progressed to a little cough), COUGH (itchy throat that progressed to a little cough), PAIN (body aches) and PYREXIA (fever). On an unknown date, the patient experienced DYSPNOEA (triouble breathing). At the time of the report, COVID-19 (covid at the time of the first dose), THROAT IRRITATION (itchy throat that progressed to a little cough), COUGH (itchy throat that progressed to a little cough), PAIN (body aches), DYSPNOEA (triouble breathing), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided Treatment medication includes Z-PAK, albuterol pump
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Gait disturbance, Headache, Musculoskeletal stiffness, Paraesthesia
Clinical narrative: Could barely move fingers; Hard to walk; Tingling in fingers; Weakness; High fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Hard to walk), PARAESTHESIA (Tingling in fingers), MUSCULOSKELETAL STIFFNESS (Could barely move fingers), ASTHENIA (Weakness) and PYREXIA (High fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (Weakness), PYREXIA (High fever) and HEADACHE (Headache). On 05-Mar-2021, the patient experienced GAIT DISTURBANCE (Hard to walk) and PARAESTHESIA (Tingling in fingers). On 09-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Could barely move fingers). At the time of the report, GAIT DISTURBANCE (Hard to walk), PARAESTHESIA (Tingling in fingers), MUSCULOSKELETAL STIFFNESS (Could barely move fingers), ASTHENIA (Weakness), PYREXIA (High fever) and HEADACHE (Headache) outcome was unknown.            No concomitant product use was provided by the reporter.  No treatment medication was provided.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-155550 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Could barely move fingers; Hard to walk; Tingling in fingers; Weakness; High fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Hard to walk), PARAESTHESIA (Tingling in fingers), MUSCULOSKELETAL STIFFNESS (Could barely move fingers), ASTHENIA (Weakness) and PYREXIA (High fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (Weakness), PYREXIA (High fever) and HEADACHE (Headache). On 05-Mar-2021, the patient experienced GAIT DISTURBANCE (Hard to walk) and PARAESTHESIA (Tingling in fingers). On 09-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Could barely move fingers). At the time of the report, GAIT DISTURBANCE (Hard to walk), PARAESTHESIA (Tingling in fingers), MUSCULOSKELETAL STIFFNESS (Could barely move fingers), ASTHENIA (Weakness), PYREXIA (High fever) and HEADACHE (Headache) outcome was unknown.            No concomitant product use was provided by the reporter.  No treatment medication was provided.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-155550 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Livedo reticularis
Clinical narrative: livedo reticularis; This spontaneous case was reported by a consumer and describes the occurrence of LIVEDO RETICULARIS (livedo reticularis) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No past medical history was reported.     On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced LIVEDO RETICULARIS (livedo reticularis). At the time of the report, LIVEDO RETICULARIS (livedo reticularis) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was received.  No product concomitant was reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (reaction to the vaccine that have shellfish allergies) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reaction to the vaccine that have shellfish allergies). At the time of the report, VACCINATION COMPLICATION (reaction to the vaccine that have shellfish allergies) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever for about 4 weeks (98-100.6); This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever for about 4 weeks (98-100.6)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 606M20A and 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer (Breast cancer + bone metastasis) since 29-Nov-2017, Hypertension, Sulfonamide allergy, Drug allergy (Dilaudid) and Tetanus (Tetanus toxoid). Concomitant products included DENOSUMAB (XGEVA) for Bone cancer metastatic, LETROZOLE for Cancer, APIXABAN (ELIQUIS) for DVT, TIMOLOL MALEATE and BRIMONIDINE TARTRATE (ALPHAGAN) for Glaucoma, CARVEDILOL (COREG) for Heart disorder, FULVESTRANT (FASLODEX) for Hormone therapy, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, MAGNESIUM for Neuropathy, CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM & VITAMIN D3) for Osteopenia, PANTOPRAZOLE for Reflux gastritis, VITAMINS NOS, VITAMIN D3, VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]), FISH OIL (OMEGA 3 FISH OIL [FISH OIL]) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 12-Feb-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021 at 12:00 PM, the patient experienced PYREXIA (fever for about 4 weeks (98-100.6)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 20-Apr-2021, PYREXIA (fever for about 4 weeks (98-100.6)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products included hormone injection once a month, cancer pill orally, heart pill for blood pressure and blood thinner, vitamins, Refresh advanced drops and refresh celluvisc gel for Cogan's syndrome. Cozaar-Losartan K (25 mg) used for BP.  Treatment products included Tylenol and Advil.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: ADR form --second dose update-- concomitant meds update-Report not scheduled for Follow up as initial report is pending for submission
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Mass, Papule, Pruritus, Rash macular
Clinical narrative: hard lumps; redness blotches; papules; itchiness; redness all over arm; This spontaneous case was reported by a consumer and describes the occurrence of PAPULE (papules), PRURITUS (itchiness), ERYTHEMA (redness all over arm), MASS (hard lumps) and RASH MACULAR (redness blotches) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE BESYLATE and ACEBUTOLOL for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAPULE (papules), PRURITUS (itchiness), ERYTHEMA (redness all over arm) and RASH MACULAR (redness blotches). On 07-Mar-2021, the patient experienced MASS (hard lumps). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAPULE (papules), PRURITUS (itchiness), ERYTHEMA (redness all over arm), MASS (hard lumps) and RASH MACULAR (redness blotches) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications were Provided.  No treatment medications were provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: The vaccination site just called & cancelled both our 13Mar2021 appointments; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The vaccination site just called & cancelled both our 13Mar2021 appointments) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No past medical history was reported.     On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The vaccination site just called & cancelled both our 13Mar2021 appointments). On 10-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The vaccination site just called & cancelled both our 13Mar2021 appointments) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up received on 21-JUN-2021 and contains no new information. Reporter declined any further follow-up.